Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Vilanterol 25mcg + Fluticasone Furoate 100mcg rota cap
Dosage Form : Rota cap
Packaging Type : Bottle
Packaging : 30 Capsules
Price : ₹1/-
Flutialfa VF is a combination inhalation therapy designed to provide effective management of asthma and chronic obstructive pulmonary disease (COPD). Each Rota Cap contains Vilanterol (25 mcg), a long-acting beta-agonist (LABA), and Fluticasone Furoate (100 mcg), a potent inhaled corticosteroid (ICS). This dual-action formulation works synergistically to improve lung function, reduce inflammation, and alleviate respiratory symptoms.
Vilanterol acts by stimulating beta-2 adrenergic receptors in the airway smooth muscle, leading to bronchodilation and improved airflow. This helps to relieve symptoms such as wheezing and shortness of breath. Fluticasone Furoate, on the other hand, reduces airway inflammation and hyperreactivity, addressing the underlying causes of asthma and COPD. Together, these components provide comprehensive control of respiratory conditions, allowing patients to breathe more easily and engage in daily activities with greater comfort.
Common side effects may include throat irritation, hoarseness, headache, and increased risk of respiratory infections. Some patients may experience palpitations or muscle cramps. It is essential to monitor for any unusual symptoms during treatment.
Flutialfa VF is indicated for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD) in adults.
Flutialfa VF should be used only as prescribed by a healthcare professional. Do not exceed the recommended dosage, and consult a doctor if symptoms do not improve or worsen
Store Flutialfa VF in a cool, dry place, away from direct sunlight and moisture. Ensure that it is kept out of reach of children.
Composition : Budesonide (0.5mg) Respule
Composition : Budesonide (100mcg) Inhaler
Composition : Budesonide (400mcg) + Formoterol (6mcg) Rota Caps
Composition : Budesonide (0.5mg) + Formoterol (20mcg) Respule
Composition : Formoterol (20mcg) + Budesonide (0.5mg) Respule
Composition : Levosalbutamol (1.25mg) + Budesonide (0.5mg) Respule
Composition : Glycopyrronium (25mcg) + Formoterol (12mcg)+ Budesonide (400 mcg) Rota Capsule
Composition : Formoterol 6mcg + Budesonide 400mcg Rota Capsule
Composition : Fluticasone Propionate 500mcg + Formoterol Fumarate 12mcg Life Cap
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Strategic Advisory
Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.
View Professional Profile
Start Your Journey
Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!
Quick Navigation